Emergence of Tigecycline Resistant Acinetobacter baumannii From an Intensive Care Unit (ICU) in Tehran

Author(s):
Afsaneh KarmostajAfsaneh Karmostaj1, Shahin Najar PeerayehShahin Najar Peerayeh1,*, Ali Hatef SalmanianAli Hatef Salmanian2
1Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IR Iran
2National Institute of Genetic Engineering and Biotechnology, Tehran, IR Iran

Jundishapur Journal of Microbiology:Vol. 6, issue 3; 215-19
Published online:Apr 30, 2013
Article type:Research Article
Received:May 23, 2012
Accepted:Aug 06, 2012
How to Cite:Karmostaj A, Najar Peerayeh S, Hatef Salmanian A. Emergence of Tigecycline Resistant Acinetobacter baumannii From an Intensive Care Unit (ICU) in Tehran. Jundishapur J Microbiol. 2013;6(3):. doi: https://doi.org/10.5812/jjm.4710

Abstract

Background:

Acinetobacter species, specially, Acinetobacter baumannii, is known, as an important opportunistic pathogen, with arnvariety of infections such as pneumonia, bacteraemia, meningitis, urinary tract, skin and soft tissue infections, associated with highrnmortality. High prevalence of multidrug resistance in A. baumannii, limits our therapeutic choices in the treatment of infectionsrncaused by this bacterium.

Objectives:

The current study aimed to determine in vitro activity of tigecycline and colistin against clinical isolates of MDR A. baumannii, from patients admitted in ICUs Tehran hospitals.

Material and Methods:

This study was conducted from March 2009 to November 2010, on a total of 91 Acinetobacter species isolatedrnfrom clinical specimens in ICUs. All isolates were subjected to PCR to detect blaOXA-51-like gene that is unique to A. baumannii. Thernantimicrobial susceptibility for 13 different antibiotics was tested.

Results:

A. baumannii (blaOXA-51-like gene) was detected in 84 (92.30%) isolates.Resistance rates in A. baumannii, were found to bernfor Imipenem 50 (59.52%), Gentamicin 65 (77.38%), Ciprofloxacin 81 (96.42%), Amikacin 44 (52.38%), Cefotaxime 81 (96.42%), Cefepimern69 (82.14%), Ceftazidim 81 (96.42%), Meropenem 74 (88.09%), Trimethoprim - sulfamethoxazole 78 (92.85%), Aztreonam 82 (97.61%),rnColistin and Polymyxin-B 0%. No interpretive criteria have been approved for tigecycline against Acinetobacter spp. so; the results wererninterpreted by the criteria recommended by Jones, and US FDA for Enterobacteriaceae. Resistance rates for tigecycline were 3 (3.57%)rn(Jones criteria) and 19 (22.61%) (FDA criteria).

Conclusions:

It is clear that new antimicrobials are needed to treat MDR A. baumannii. Polymyxins and tigecycline are among the fewrnantibiotics available to treat infections with these bacteria but little was known about the antimicrobial activity of these agents. ThernPresent study provided valuable information about the effects of the above mentioned drugs that can be used for health policy. Itrnshould be noted that there is a need for regular surveillance of bacterial resistance to these antimicrobial agents.

Full Text

Full text is available in PDF

Similar Articles

1
Feb
2014

Evaluation of Ciprofloxacin (gyrA, parC Genes) and Tetracycline (tetB Gene) Resistance in Nosocomial Acinetobacter baumannii Infections

Jamileh Nowroozi,
Abbas Akhavan Sepahi,
Lida Tahmasebinejad Kamarposhti,
Roya Razavipour,
Flor Mazhar

Nowroozi J, Akhavan Sepahi A, Tahmasebinejad Kamarposhti L, Razavipour R, Mazhar F. Evaluation of Ciprofloxacin (gyrA, parC Genes) and Tetracycline (tetB Gene) Resistance in Nosocomial Acinetobacter baumannii Infections. Jundishapur J Microbiol. 2014;7(2):e8976. doi: https://doi.org/10.5812/jjm.8976

15
Dec
2021
J Clin Res Paramed Sci

Antibiotic Resistance Pattern and Prevalence of blaOXA-51, blaNDM, blaVIM, blaPER, blaVEB, blaCTX, tetA and tetB Genes in Acinetobacter baumannii Isolated from Clinical Specimens of Hospitals in Tabriz city, Iran

Abolfazl Jafari Sales,
Sara Naebi,
Hossein Bannazadeh-Baghi,
Morteza Saki

Jafari Sales A, Naebi S, Bannazadeh-Baghi H, Saki M. Antibiotic Resistance Pattern and Prevalence of blaOXA-51, blaNDM, blaVIM, blaPER, blaVEB, blaCTX, tetA and tetB Genes in Acinetobacter baumannii Isolated from Clinical Specimens of Hospitals in Tabriz city, Iran. J Clin Res Paramed Sci. 2021;10(2):e118521. doi: https://doi.org/10.5812/jcrps.118521

1
Oct
2013

Nosocomial Outbreak of Extensively and Pan Drug-Resistant Acinetobacter baumannii in Tertiary Hospital in Central Part of Iran

Alireza Japoni-Nejad,
Masoomeh Sofian,
Alex van Belkum,
Ehsanollah Ghaznavi-Rad

Japoni-Nejad A, Sofian M, Belkum AV, Ghaznavi-Rad E. Nosocomial Outbreak of Extensively and Pan Drug-Resistant Acinetobacter baumannii in Tertiary Hospital in Central Part of Iran. Jundishapur J Microbiol. 2013;6(8):e9892. doi: https://doi.org/10.5812/jjm.9892

24
Apr
2016

Beta-Lactamase Encoded Genes blaTEM and blaCTX Among Acinetobacter baumannii Species Isolated From Medical Devices of Intensive Care Units in Tehran Hospitals

Sara Khalilzadegan,
Mojtaba Sade,
Hussein Godarzi,
Gita Eslami,
Masoumeh Hallajzade,
Fatemeh Fallah
,et al.

Khalilzadegan S, Sade M, Godarzi H, Eslami G, Hallajzade M, et al. Beta-Lactamase Encoded Genes blaTEM and blaCTX Among Acinetobacter baumannii Species Isolated From Medical Devices of Intensive Care Units in Tehran Hospitals. Jundishapur J Microbiol. 2016;9(5):e14990. doi: https://doi.org/10.5812/jjm.14990

22
Apr
2018
Antibiotic Resistance in <i>Acinetobacter baumannii</i> Isolated from Patients with Urinary Tract Infections in Zabol, Iran

Antibiotic Resistance in Acinetobacter baumannii Isolated from Patients with Urinary Tract Infections in Zabol, Iran

Khadije Rezaie Keikhaie,
Leili Rezaie Keikhaie,
Saphora Bazi,
Fereshteh Javadian

Rezaie Keikhaie K, Rezaie Keikhaie L, Bazi S, Javadian F. Antibiotic Resistance in Acinetobacter baumannii Isolated from Patients with Urinary Tract Infections in Zabol, Iran. Int J Infect. 2018;5(2):e60181. doi: https://doi.org/10.5812/iji.60181


Crossmark
Crossmark
Checking
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles